Moderna stock rises 5.6 percent at the close
Published on 09/23/2026 at 23:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Moderna stock closed at USD 183.08 on the Nasdaq on September 23, 2026, up 5.6 percent from the prior close of USD 172.94. The gain contrasted with the S&P 500, which declined 0.3 percent on the same session, according to GuruFocus.
September 23, 2026 in numbers
Moderna Inc. (ISIN US60770K1079, Nasdaq: MRNA) reached the top of its reported 52-week range, which ran from USD 22.36 to USD 183.08. Reported volume was 20,238,545 shares, while the session profile also placed the stock at its highest level in that range.
The move followed new melanoma vaccine developments. Three research abstracts on Moderna's intismeran autogene were accepted for presentation at the European Society for Medical Oncology Congress in Madrid from October 23 through October 27, 2026, according to AD HOC NEWS.
Clinical data due in October
The ESMO Congress presentation runs from October 23 through October 27, 2026, giving the melanoma program its next stated clinical checkpoint. The stock therefore ended September 23 at its reported 52-week high after a 5.6 percent advance, while the broader S&P 500 fell 0.3 percent.
